Who we are
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar commercial markets. We are committed to translating innovative science into medicines that transform the lives of patients with various diseases. more...
sell Cancer-Associated Fibroblasts (“CAFs”) and native fibroblasts developed by
us directly to leading institutions, clinics, investigators and sponsors,
including major biotechnology/biopharmaceutical firms and several universities.
These institutions use CAFs and native fibroblasts for advanced cancer
research, especially for the development of immunotherapy for the treatment of
We have developed a variety of research grade formulations of MSC-Gro through over 20 years of research and development. We have low serum, serum-free and CAF-specific formulations, which we believe confers additional benefits to cellular immunotherapy development and stem cell research and generates increased ATP expression (an energy molecule), viability, immunosuppression measurement and yield.